0000899243-20-011298.txt : 20200424
0000899243-20-011298.hdr.sgml : 20200424
20200424165951
ACCESSION NUMBER: 0000899243-20-011298
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20200207
FILED AS OF DATE: 20200424
DATE AS OF CHANGE: 20200424
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Societe des Produits Nestle S.A.
CENTRAL INDEX KEY: 0001803539
STATE OF INCORPORATION: V8
FISCAL YEAR END: 1231
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-37519
FILM NUMBER: 20815825
BUSINESS ADDRESS:
STREET 1: AVENUE NESTLE 55
CITY: VEVEY
STATE: V8
ZIP: CH-1800
BUSINESS PHONE: 41-21-924-1111
MAIL ADDRESS:
STREET 1: AVENUE NESTLE 55
CITY: VEVEY
STATE: V8
ZIP: CH-1800
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: NESTLE SA
CENTRAL INDEX KEY: 0000792990
STANDARD INDUSTRIAL CLASSIFICATION: FOOD & KINDRED PRODUCTS [2000]
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-37519
FILM NUMBER: 20815826
BUSINESS ADDRESS:
STREET 1: AVE NESELE 55, CH-1800
CITY: VEVEY
STATE: V8
BUSINESS PHONE: 01141219241111
MAIL ADDRESS:
STREET 1: AVE NESTLE 55
STREET 2: CH-1800
CITY: VEVEY
STATE: V8
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: Aimmune Therapeutics, Inc.
CENTRAL INDEX KEY: 0001631650
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
IRS NUMBER: 452748244
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 8000 MARINA BOULEVARD
STREET 2: SUITE 300
CITY: BRISBANE
STATE: CA
ZIP: 94005-1884
BUSINESS PHONE: (650) 614-5220
MAIL ADDRESS:
STREET 1: 8000 MARINA BOULEVARD
STREET 2: SUITE 300
CITY: BRISBANE
STATE: CA
ZIP: 94005-1884
FORMER COMPANY:
FORMER CONFORMED NAME: Allergen Research Corp
DATE OF NAME CHANGE: 20150123
4
1
doc4.xml
FORM 4 SUBMISSION
X0306
4
2020-02-07
0
0001631650
Aimmune Therapeutics, Inc.
AIMT
0001803539
Societe des Produits Nestle S.A.
AVENUE NESTLE 55
CH-1800, VEVEY
V8
SWITZERLAND
0
0
1
0
0000792990
NESTLE SA
AVENUE NESTLE 55
CH-1800, VEVEY
V8
SWITZERLAND
0
0
1
0
Common Stock
2020-02-07
4
P
0
1000000
31.97
A
12727113
I
See Footnote
Series A Preferred Stock
2020-02-07
4
P
0
525634
319.675
A
525634
I
See Footnote
Common Stock
2020-04-22
4
J
0
12727113
16.11
A
12727113
I
See Footnote
Series A Preferred Stock
2020-04-22
4
J
0
525634
161.10
A
525634
I
See Footnote
Consists of 12,727,113 shares of Common Stock held by Nestle Health Science US Holdings, Inc. ("NHS"). NHS is a wholly owned subsidiary of NIMCO US, Inc. ("NIMCO"). NIMCO, in turn, is a wholly-owned subsidiary of Nestle US Holdco, Inc. ("Nestle US Holdco"), which is a wholly-owned subsidiary of Societe des Products Nestle S.A.("SPN"). The ultimate parent company of NHS, NIMCO, Nestle US Holdco and SPN is Nestle S.A. ("Nestle"). Following the purchase referred to in the table above and prior to the internal transfer referred to in Note 3 below, each of these entities may be deemed to share voting and investment power with respect to all shares of Common Stock held by NHS. Each of NIMCO, Nestle US Holdco, SPN and Nestle disclaims beneficial ownership of such shares of Common Stock except to the extent of its pecuniary interest therein.
Consists of 525,634 shares of Series A Preferred Stock held by NHS with each share of Series A Preferred Stock convertible into ten shares of Common Stock. Following the purchase and prior to the internal transfer referred to in Note 3 below, each of NHS, NIMCO, Nestle US Holdco, SPN and Nestle may be deemed to share voting and investment power with respect to these shares of Series A Preferred Stock held by NHS. Each of NIMCO, Nestle US Holdco, SPN and Nestle disclaims beneficial ownership of such shares of Series A Preferred Stock except to the extent of its pecuniary interest therein.
This transaction constitutes an internal transfer of 12,727,113 shares of Common Stock and 525,634 shares of Series A Preferred Stock from NHS to SPN. Following the transfer, SPN and Nestle may be deemed to share voting and investment power with respect to all shares of Common Stock and Series A Preferred Stock. Nestle disclaims beneficial ownership of such shares of Common Stock and Series A Preferred Stock except to the extent of its pecuniary interest therein. Subsequent to this internal transfer, each of NHS, NIMCO, and Nestle US Holdco no longer hold any shares of Common Stock or Series A Preferred Stock and are therefore no longer Reporting Owners.
NESTLE HEALTH SCIENCE US HOLDINGS, INC. By: Name: James Pepin, Title: Director and President
2020-04-24
NIMCO US, INC. By: Name: Dan Nugent, Title: Chief Legal Officer and General Counsel
2020-04-24
NESTLE US HOLDCO, INC. By: Name: Michael Prewitt, Title: Secretary
2020-04-24
SOCIETE DES PRODUITS NESTLE S.A. By: Name: Claudio Kuoni, Title: Vice President
2020-04-24
NESTLE S.A. By: Name: Gregory Behar, Title: Deputy Executive Vice President
2020-04-24